Over the course of my education as a graduate student in psychology and my experience as
a staff member in a psychiatric unit, I have had the opportunity to learn a lot about …

PURPOSE We aimed to determine the effectiveness of interventions to manage
antidepressant discontinuation, and the outcomes for patients. METHODS We conducted a …

The splitting of scored tablets provides many advantages. One benefit is to achieve dose
flexibility to account for the huge interindividual differences in dose requirements for …

Background: Long-term antidepressant use has increased exponentially, though this is not
always according to guidelines. Our previous randomized controlled trial (RCT) showed that …

Background Many people experience withdrawal symptoms when they attempt to stop
antidepressants. Withdrawal symptoms are readily misconstrued for relapse or ongoing …

Paroxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. In
contrast to other SSRIs, it has a relatively short half‐life and lacks active metabolites. In three …

Introduction The incidence and severity of withdrawal effects when coming off
antidepressants (ADs) have recently received considerable attention. National guidelines on …

Withdrawal reactions when coming off antidepressants have long been neglected or
minimised. It took almost two decades after the selective serotonin reuptake inhibitors …

Background: The newer antidepressants are among the most commonly prescribed classes
of medications. A favourable adverse effect profile and approvals for a wider range of …

Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term
'discontinuation syndrome'are not supported by evidence. Acknowledging that SSRI use can …